0001926434-24-000001.txt : 20240403 0001926434-24-000001.hdr.sgml : 20240403 20240403150943 ACCESSION NUMBER: 0001926434-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 EFFECTIVENESS DATE: 20240403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CESSATION THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001926434 ORGANIZATION NAME: IRS NUMBER: 823906297 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-509539 FILM NUMBER: 24818320 BUSINESS ADDRESS: STREET 1: 3031 TISCH WAY, STE. 505 CITY: SAN JOSE STATE: CA ZIP: 95128 BUSINESS PHONE: 408-479-7843 MAIL ADDRESS: STREET 1: 3031 TISCH WAY, STE. 505 CITY: SAN JOSE STATE: CA ZIP: 95128 D 1 primary_doc.xml X0708 D LIVE 0001926434 CESSATION THERAPEUTICS, INC. 12200 Stemmons Freeway Suite 100 Dallas TX TEXAS 75234 408-479-7843 DELAWARE None None Corporation true 2022 Andrew Barrett 12200 Stemmons Freeway Suite 100 Dallas TX TEXAS 75234 Executive Officer John Harkey 12200 Stemmons Freeway Suite 100 Dallas TX TEXAS 75234 Director Mark Pearson 12200 Stemmons Freeway Suite 100 Dallas TX TEXAS 75234 Director Daniel Fine 12200 Stemmons Freeway Suite 100 Dallas TX TEXAS 75234 Director Jay Shepard 12200 Stemmons Freeway Suite 100 Dallas TX TEXAS 75234 Director Sharon Tetlow 12200 Stemmons Freeway Suite 100 Dallas TX TEXAS 75234 Director Biotechnology Decline to Disclose 06b false 2024-03-29 false true true true false 0 1000000 1000000 0 false 2 0 0 0 false CESSATION THERAPEUTICS, INC. /s/ Andrew C. Barrett Andrew C. Barrett CEO 2024-04-03